| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | Apr 16, 2024 | Option Exercise | $23.23 | 20,000 | 464,600 | 178,176 | Apr 17, 2024, 07:22 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | Apr 17, 2024 | Option Exercise | $23.30 | 20,000 | 465,990 | 178,176 | Apr 17, 2024, 07:22 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | Mar 26, 2024 | Option Exercise | $11.20 | 11,618 | 130,160 | 168,176 | Mar 26, 2024, 07:38 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | Mar 13, 2024 | Option Exercise | $26.47 | 20,000 | 529,368 | 166,558 | Mar 13, 2024, 05:22 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | Mar 12, 2024 | Sale | $26.85 | 20,000 | 537,070 | 166,558 | Mar 13, 2024, 05:22 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | Feb 27, 2024 | Sale | $39.95 | 10,000 | 399,460 | 159,087 | Feb 28, 2024, 06:49 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | Feb 28, 2024 | Sale | $26.10 | 17,471 | 456,053 | 164,029 | Feb 28, 2024, 06:49 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | Feb 16, 2024 | Option Exercise | $36.10 | 5,257 | 189,778 | 169,087 | Feb 20, 2024, 06:59 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | Snyder Mark Howard | SVP, GENERAL COUNSEL | Feb 16, 2024 | Option Exercise | $36.10 | 2,577 | 93,030 | 11,680 | Feb 20, 2024, 06:55 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBrosse Nicole | SVP, CHIEF FINANCIAL OFFICER | Feb 16, 2024 | Option Exercise | $36.10 | 5,601 | 202,196 | 15,480 | Feb 20, 2024, 06:53 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | Feb 16, 2024 | Option Exercise | $36.10 | 20,362 | 735,068 | 676,744 | Feb 20, 2024, 06:49 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | Feb 15, 2024 | Option Exercise | $35.91 | 5,040 | 180,986 | 163,968 | Feb 16, 2024, 05:47 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBrosse Nicole | SVP, CHIEF FINANCIAL OFFICER | Feb 15, 2024 | Option Exercise | $35.91 | 686 | 24,634 | 10,659 | Feb 16, 2024, 05:41 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | Feb 15, 2024 | Option Exercise | $35.91 | 24,655 | 885,361 | 659,222 | Feb 16, 2024, 05:39 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | Feb 10, 2024 | Option Exercise | $35.49 | 2,901 | 102,956 | 157,143 | Feb 13, 2024, 04:18 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBrosse Nicole | SVP, CHIEF FINANCIAL OFFICER | Feb 10, 2024 | Option Exercise | $35.49 | 1,477 | 52,419 | 10,091 | Feb 13, 2024, 04:15 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | Feb 10, 2024 | Option Exercise | $35.49 | 16,943 | 601,307 | 638,004 | Feb 13, 2024, 04:12 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | Jan 16, 2024 | Sale | $24.03 | 20,000 | 480,700 | 161,911 | Jan 18, 2024, 04:07 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | Jan 17, 2024 | Sale | $24.03 | 20,000 | 480,700 | 161,911 | Jan 18, 2024, 04:07 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | Snyder Mark Howard | SVP, GENERAL COUNSEL | Jan 03, 2024 | Option Exercise | $35.78 | 2,957 | 105,801 | 9,461 | Jan 05, 2024, 04:04 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | Dec 12, 2023 | Sale | $26.59 | 20,000 | 531,870 | 161,911 | Dec 13, 2023, 07:48 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | Dec 13, 2023 | Option Exercise | $26.23 | 20,000 | 524,640 | 161,911 | Dec 13, 2023, 07:48 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | Nov 14, 2023 | Sale | $26.70 | 20,000 | 533,963 | 160,203 | Nov 16, 2023, 04:18 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | Nov 15, 2023 | Sale | $26.80 | 20,000 | 535,980 | 161,911 | Nov 16, 2023, 04:18 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | Oct 17, 2023 | Sale | $28.25 | 20,000 | 565,000 | 161,911 | Oct 17, 2023, 07:28 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | Sep 19, 2023 | Sale | $29.54 | 20,000 | 590,780 | 161,911 | Sep 19, 2023, 04:09 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | Aug 29, 2023 | Option Exercise | $28.14 | 20,000 | 562,720 | 633,666 | Aug 31, 2023, 05:35 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | Aug 30, 2023 | Sale | $28.36 | 20,000 | 567,240 | 633,666 | Aug 31, 2023, 05:35 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | Aug 31, 2023 | Sale | $28.34 | 20,000 | 566,870 | 633,666 | Aug 31, 2023, 05:35 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | Aug 22, 2023 | Option Exercise | $31.04 | 20,000 | 620,848 | 159,986 | Aug 23, 2023, 05:08 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | Aug 15, 2023 | Option Exercise | $28.82 | 20,000 | 576,380 | 633,666 | Aug 17, 2023, 05:29 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | Aug 16, 2023 | Option Exercise | $28.70 | 20,000 | 574,020 | 633,666 | Aug 17, 2023, 05:29 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | Aug 17, 2023 | Option Exercise | $28.53 | 20,000 | 570,520 | 633,666 | Aug 17, 2023, 05:29 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | Daly James M | Director | Aug 11, 2023 | Sale | $43.71 | 10,000 | 437,110 | 30,503 | Aug 15, 2023, 04:04 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | Daly James M | Director | Aug 14, 2023 | Sale | $43.74 | 10,000 | 437,410 | 20,503 | Aug 15, 2023, 04:04 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | Jul 25, 2023 | Sale | $28.33 | 20,000 | 566,660 | 633,666 | Jul 27, 2023, 04:03 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | Jul 26, 2023 | Option Exercise | $28.28 | 20,000 | 565,590 | 633,666 | Jul 27, 2023, 04:03 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | Jul 27, 2023 | Option Exercise | $28.83 | 20,000 | 576,600 | 633,666 | Jul 27, 2023, 04:03 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | Jul 18, 2023 | Sale | $23.68 | 30,000 | 710,398 | 151,911 | Jul 19, 2023, 04:10 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | Jun 21, 2023 | Sale | $27.20 | 20,000 | 544,100 | 151,911 | Jun 22, 2023, 06:20 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | Apr 18, 2023 | Sale | $27.20 | 20,000 | 544,100 | 151,911 | Apr 19, 2023, 06:07 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | Feb 27, 2023 | Sale | $33.98 | 5,968 | 202,790 | 144,895 | Apr 19, 2023, 06:01 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | Mar 07, 2023 | Sale | $30.06 | 20,000 | 601,290 | 633,666 | Mar 09, 2023, 05:04 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | Mar 08, 2023 | Sale | $28.96 | 20,000 | 579,190 | 633,666 | Mar 09, 2023, 05:04 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | Mar 09, 2023 | Sale | $28.69 | 20,000 | 573,870 | 633,666 | Mar 09, 2023, 05:04 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | Henderson Jeffrey William | Director | Mar 01, 2023 | Sale | $47.71 | 10,000 | 477,100 | 39,045 | Mar 01, 2023, 06:07 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | Henderson Jeffrey William | Director | Feb 28, 2023 | Sale | $48.51 | 10,000 | 485,100 | 49,045 | Mar 01, 2023, 06:07 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | Feb 27, 2023 | Sale | $49.55 | 10,000 | 495,483 | 141,911 | Feb 28, 2023, 04:59 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | Feb 16, 2023 | Sale | $49.26 | 2,878 | 141,770 | 148,927 | Feb 21, 2023, 07:05 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBrosse Nicole | SVP, CHIEF FINANCIAL OFFICER | Feb 16, 2023 | Sale | $49.26 | 2,525 | 124,381 | 9,066 | Feb 21, 2023, 07:00 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | Feb 16, 2023 | Sale | $49.26 | 11,061 | 544,865 | 633,666 | Feb 21, 2023, 06:59 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | Feb 15, 2023 | Option Exercise | $48.48 | 11,170 | 541,504 | 145,693 | Feb 17, 2023, 06:29 AM | |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBrosse Nicole | SVP, CHIEF FINANCIAL OFFICER | Feb 15, 2023 | Option Exercise | $49.20 | 621 | 30,553 | 6,497 | Feb 17, 2023, 06:25 AM | |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | Feb 15, 2023 | Option Exercise | $49.20 | 6,892 | 339,086 | 623,717 | Feb 17, 2023, 06:20 AM | |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | Feb 10, 2023 | Option Exercise | $48.92 | 2,951 | 144,363 | 148,319 | Feb 14, 2023, 05:24 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | Feb 12, 2023 | Option Exercise | $48.92 | 2,725 | 133,307 | 153,477 | Feb 14, 2023, 05:24 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBrosse Nicole | SVP, CHIEF FINANCIAL OFFICER | Feb 10, 2023 | Option Exercise | $48.92 | 1,392 | 68,097 | 5,156 | Feb 14, 2023, 05:21 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBrosse Nicole | SVP, CHIEF FINANCIAL OFFICER | Feb 12, 2023 | Option Exercise | $48.92 | 681 | 33,315 | 5,864 | Feb 14, 2023, 05:21 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | Feb 10, 2023 | Option Exercise | $48.92 | 16,469 | 805,663 | 601,989 | Feb 14, 2023, 05:17 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | Feb 12, 2023 | Option Exercise | $48.92 | 17,266 | 844,653 | 617,517 | Feb 14, 2023, 05:17 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | Feb 09, 2023 | Option Exercise | $32.53 | 20,000 | 650,600 | 597,177 | Feb 09, 2023, 05:44 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | Feb 07, 2023 | Option Exercise | $32.96 | 20,000 | 659,180 | 597,177 | Feb 09, 2023, 05:44 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | Feb 08, 2023 | Option Exercise | $33.01 | 20,000 | 660,170 | 597,177 | Feb 09, 2023, 05:44 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | Jan 17, 2023 | Sale | $32.56 | 20,000 | 651,139 | 597,177 | Jan 19, 2023, 05:07 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | Jan 18, 2023 | Option Exercise | $32.85 | 20,000 | 657,070 | 597,177 | Jan 19, 2023, 05:07 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | Jan 19, 2023 | Option Exercise | $33.54 | 20,000 | 670,740 | 597,177 | Jan 19, 2023, 05:07 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | Jan 17, 2023 | Sale | $50.46 | 10,000 | 504,590 | 144,259 | Jan 18, 2023, 07:07 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | Snyder Mark Howard | SVP, GENERAL COUNSEL | Jan 03, 2023 | Option Exercise | $55.13 | 2,804 | 154,585 | 4,807 | Jan 04, 2023, 06:00 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | Dec 13, 2022 | Sale | $36.66 | 20,000 | 733,227 | 597,177 | Dec 15, 2022, 07:12 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | Dec 14, 2022 | Option Exercise | $36.48 | 20,000 | 729,580 | 597,177 | Dec 15, 2022, 07:12 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | Dec 15, 2022 | Sale | $36.01 | 20,000 | 720,294 | 597,177 | Dec 15, 2022, 07:12 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | Dec 13, 2022 | Sale | $58.67 | 10,000 | 586,675 | 158,202 | Dec 13, 2022, 06:09 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | Posard Matthew L. | Director | Dec 02, 2022 | Sale | $58.80 | 10,000 | 588,000 | 125,189 | Dec 06, 2022, 07:07 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | Posard Matthew L. | Director | Dec 05, 2022 | Sale | $55.74 | 10,000 | 557,370 | 115,189 | Dec 06, 2022, 07:07 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | Posard Matthew L. | Director | Dec 06, 2022 | Sale | $56.12 | 10,000 | 561,180 | 105,189 | Dec 06, 2022, 07:07 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | Nov 16, 2022 | Option Exercise | $34.28 | 20,000 | 685,590 | 597,177 | Nov 17, 2022, 05:09 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | Nov 17, 2022 | Option Exercise | $33.40 | 20,000 | 668,090 | 597,177 | Nov 17, 2022, 05:09 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | Nov 15, 2022 | Sale | $34.39 | 20,000 | 687,746 | 597,177 | Nov 17, 2022, 05:09 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBrosse Nicole | SVP, CHIEF FINANCIAL OFFICER | Nov 15, 2022 | Sale | $53.81 | 5,000 | 269,053 | 4,410 | Nov 16, 2022, 07:51 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | Nov 15, 2022 | Sale | $54.13 | 10,000 | 541,263 | 166,260 | Nov 16, 2022, 07:25 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief Technical Officer | Feb 15, 2022 | Option Exercise | $34.43 | 1,170 | 40,283 | 173,137 | Feb 17, 2022, 06:04 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBrosse Nicole | SVP, Chief Financial Officer | Feb 15, 2022 | Option Exercise | $34.43 | 433 | 14,908 | 9,045 | Feb 17, 2022, 06:03 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | President and CEO | Feb 15, 2022 | Option Exercise | $34.43 | 6,892 | 237,292 | 587,177 | Feb 17, 2022, 06:02 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief Technical Officer | Feb 12, 2022 | Option Exercise | $34.20 | 2,725 | 93,195 | 167,145 | Feb 14, 2022, 07:29 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief Technical Officer | Feb 14, 2022 | Option Exercise | $33.64 | 1,995 | 67,112 | 170,921 | Feb 14, 2022, 07:29 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief Technical Officer | Feb 10, 2022 | Option Exercise | $34.94 | 2,992 | 104,540 | 161,987 | Feb 14, 2022, 07:29 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBrosse Nicole | SVP, Chief Financial Officer | Feb 10, 2022 | Option Exercise | $34.94 | 1,025 | 35,813 | 6,511 | Feb 14, 2022, 07:28 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBrosse Nicole | SVP, Chief Financial Officer | Feb 12, 2022 | Option Exercise | $34.20 | 506 | 17,305 | 7,394 | Feb 14, 2022, 07:28 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBrosse Nicole | SVP, Chief Financial Officer | Feb 14, 2022 | Option Exercise | $33.64 | 427 | 14,364 | 8,223 | Feb 14, 2022, 07:28 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | President and CEO | Feb 10, 2022 | Option Exercise | $34.94 | 16,598 | 579,934 | 551,844 | Feb 14, 2022, 07:27 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | President and CEO | Feb 12, 2022 | Option Exercise | $34.20 | 17,266 | 590,497 | 567,373 | Feb 14, 2022, 07:27 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | President and CEO | Feb 14, 2022 | Option Exercise | $33.64 | 15,125 | 508,805 | 580,977 | Feb 14, 2022, 07:27 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | President and CEO | Nov 08, 2021 | Sale | $27.24 | 100,000 | 2,723,768 | 587,160 | Nov 08, 2021, 06:22 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | MATSUI CONNIE | Director | Nov 05, 2021 | Sale | $40.38 | 32,000 | 1,292,113 | 194,531 | Nov 05, 2021, 05:59 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief Technical Officer | Oct 12, 2021 | Option Exercise | $13.10 | 8,050 | 105,455 | 156,846 | Oct 12, 2021, 07:06 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | President and CEO | Oct 04, 2021 | Sale | $27.37 | 100,000 | 2,737,390 | 587,160 | Oct 04, 2021, 07:37 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, Chief Technical Officer | Oct 01, 2021 | Sale | $26.52 | 58,900 | 1,561,763 | 178,246 | Oct 01, 2021, 07:32 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | President and CEO | Sep 07, 2021 | Sale | $28.52 | 100,000 | 2,851,846 | 587,160 | Sep 07, 2021, 05:46 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | Matsuda Masaru | SVP, General Counsel | Sep 04, 2021 | Option Exercise | $42.22 | 3,412 | 144,055 | 20,049 | Sep 07, 2021, 05:42 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | BIZZARI JEAN-PIERRE | Director | Aug 25, 2021 | Sale | $41.01 | 35,000 | 1,435,455 | 52,544 | Aug 25, 2021, 05:54 PM |
Menu